Literature DB >> 11193912

Combined radiation and 9-nitrocamptothecin (rubitecan) in the treatment of locally advanced pancreatic cancer.

K R Kemp1, J G Liehr, B Giovanella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11193912     DOI： 10.1111/j.1749-6632.2000.tb07054.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  3 in total

Review 1.  Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

Authors:  Fengzhi Li; Tao Jiang; Qingyong Li; Xiang Ling
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

Review 2.  Chemotherapeutic advances in pancreatic cancer.

Authors:  Jordan D Berlin; Mace L Rothenberg
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

3.  Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines.

Authors:  Robert T Dorr; Mary Ann Raymond; Terry H Landowski; Nicholas O Roman; Shoji Fukushima
Journal:  Int J Gastrointest Cancer       Date:  2005
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.